Evoke Pharma, Inc. (EVOK)

USD 4.4

(-3.3%)

Market Cap (In USD)

6.53 Million

Revenue (In USD)

5.18 Million

Net Income (In USD)

-7.79 Million

Avg. Volume

67.63 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.54-14.16
PE
-
EPS
-
Beta Value
0.348
ISIN
US30049G2030
CUSIP
30049G104
CIK
1403708
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Matthew J. D'Onofrio MBA
Employee Count
-
Website
https://www.evokepharma.com
Ipo Date
2013-09-25
Details
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.